Clinical Trials on Insufficient Metabolic Control

Total 91221 results

ikfe-CRO GmbH
IKFE Institute for Clinical Research and Development

Completed

Beta-Cell Function of Insulin Glargine Compared to Neutral Protamine Hagedorn (NPH) Insuline and to Insulin Detemir in Combination With Metformin

Type 2 Diabetic Patients | Insufficient Metabolic Control | OAD Treatment

Germany
AstraZeneca

Completed

Safety Study to Evaluate the Effects of Mild and Moderate Renal Impairment on the Pharmacokinetics of ABT-335 and Rosuvastatin When Administered Concomitantly

Dyslipidemia, Renal Insufficiency

United States
Centre Hospitalier St Esprit

Unknown

The Early Administration of Sodium Thiosulfate Should Help to Reduce the Mortality of Dialysis Patients With Calciphylaxis, From a National Cohort

Renal Insufficiency, Chronic | Calciphylaxis

France
Mitsubishi Tanabe Pharma Corporation

Completed

A Study of MCI-196 in Chronic Kidney Disease Subjects on Dialysis With Hyperphosphatemia and Dyslipidaemia

Dyslipidemia | Chronic Kidney Disease | Hyperphosphatemia | Dialysis

Poland, Ukraine, Serbia, Russian Federation, Hungary, Malaysia, Italy, Macedonia, The Former Yugoslav Republic of
Herlev Hospital

Completed

Acute Changes in the Mineral Metabolism After a High Phosphorous Containing Meal in Dialysis Patients

Chronic Kidney Disease Stage 5 | Mineral Metabolism Disorder

Denmark
Merck Sharp & Dohme LLC

Completed

Pharmacokinetics of Anacetrapib (MK0859) in Patients With Hepatic Insufficiency (MK-0859-039)

Dyslipidemia
Weill Medical College of Cornell University

Unknown

Vitamin D and Glucose Metabolism in Pediatrics

Obesity | Insulin Resistance | Vitamin D25 Insufficiency

United States
Sanofi

Completed

Evaluation of Renvela in Patients With Chronic Kidney Disease Not On Dialysis And Hyperphosphatemia In China (RECOVER)

Hyperphosphatemia

China
Federico II University

Unknown

Egg White for Phosphorus Control in Haemodialysis Patients (UAUDIPE)

Renal Insufficiency, Chronic | Hyperphosphatemia | Dialysis

Italy
Genzyme, a Sanofi Company

Terminated

A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Sevelamer Carbonate Tablets Dosed Three Times a Day in Hyperphosphataemic Chronic Kidney Disease Patients Not on Dialysis (ASPIRE)

Chronic Kidney Disease | Hyperphosphatemia

Germany, Greece, Portugal, Austria, France, Hungary, Italy, Spain, Sweden
Astellas Pharma Inc

Completed

A Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis

Chronic Kidney Disease | Hyperphosphatemia

Japan
Assistance Publique - Hôpitaux de Paris

Completed

Prevalence of Hypoglycaemia in Congenital Adrenal Insufficiency (GLYSUR)

Adrenal Insufficiency, Congenital

France
Chugai Pharmaceutical

Completed

A Phase1 Study to Explore the Safety of EOS789 in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis

Hyperphosphatemia

United States
Genzyme, a Sanofi Company

Completed

An Efficacy and Safety Study of Sevelamer Carbonate in Hyperphosphatemic Pediatric Participants With Chronic Kidney Disease

Chronic Kidney Disease | Hyperphosphatemia

United States, France, Germany, Lithuania, Poland
Fresenius Medical Care Deutschland GmbH

Completed

Therapeutic Equivalence of OsvaRen® Tablets and OsvaRen® Granules (OsvaRenNEW)

Chronic Kidney Disease | Hyperphosphatemia

Germany
Mitsubishi Tanabe Pharma Corporation

Completed

A Phase III, Multicentre, Double-Blind, Placebo-Controlled Withdrawal Study in Patients With Hyperphosphatemia

Chronic Kidney Disease | Hyperphosphatemia

France, Poland, United Kingdom, Spain, South Africa, Australia, Czech Republic, Germany, Hungary, Italy, Austria
Bayer
Shire

Completed

Study in Chronic Kidney Disease (CKD) Not on Dialysis

Hyperphosphatemia

Japan
Denver Nephrologists, P.C.
CM&D Pharma Limited

Completed

Double Blind Randomized Placebo Controlled Trial of FOSTRAP Chewing Gum in Patients With CKD and Hyperphosphatemia

Chronic Kidney Disease | Hyperphosphatemia

United States
Mitsubishi Tanabe Pharma Corporation

Completed

Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia

Chronic Kidney Disease | Hyperphosphatemia | Dialysis

United States, Canada
Mitsubishi Tanabe Pharma Corporation

Terminated

A Phase III, Multi-Centre, Randomised, Placebo-Controlled Study in Combination With Ca-based P Binders in Patients With Hyperphosphatemia

Chronic Kidney Disease | Hyperphosphatemia | Dialysis

France, Poland, Spain, Serbia, South Africa, Czech Republic, Germany, Macedonia, The Former Yugoslav Republic of, Italy, United Kingdom
Bastyr University

Recruiting

Environmental Toxicants Avoidance Study (NPETA-GD)

Glucose Intolerance | Pollution; Exposure | Glycemic Control

United States
Shire

Completed

A Study to Assess the Pharmacokinetics of Lanthanum Carbonate, Investigate and Compare the Efficacy, Safety and Tolerability of Lanthanum Carbonate With Calcium Carbonate in Hyperphosphataemic Children and Adolescents With Chronic Kidney Disease on Dialysis

Chronic Kidney Disease | Hyperphosphatemia

Germany, Argentina, Chile, Czechia, Hungary, Poland, Romania, Russian Federation, Turkey
Novartis

Completed

Placebo Versus SBR759 in Lowering Phosphate in Dialysis Patients (SBR759)

Chronic Kidney Disease | Hyperphosphatemia

Belgium, Italy
Mitsubishi Tanabe Pharma Corporation

Completed

Drug-Drug Interaction Study to Evaluate the Effect of Colestilan on the Pharmacokinetics of Single Doses of Candesartan Cilexetil in Healthy Subjects

Chronic Kidney Disease | Hyperphosphatemia

United Kingdom
KDL Inc.

Completed

A Study of HS219 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia

Chronic Kidney Disease | Hyperphosphatemia

Japan
Astellas Pharma Inc

Completed

Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis

Renal Insufficiency | Chronic Kidney Disease | Hyperphosphatemia

Japan
Bayer
Shire

Completed

Long-term Study in Chronic Kidney Disease (Extension From Study 14817)

Hyperphosphatemia

Japan
Genzyme, a Sanofi Company

Completed

An Open Label Dose Titration of Sevelamer Carbonate Tabs 3 Times a Day in Hyperphosphatemic CKD Patients Not On Dialysis

Chronic Kidney Disease | Hyperphosphatemia

United Kingdom, Australia, Denmark, France, Germany
Astellas Pharma Inc

Completed

A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis

Renal Insufficiency | Chronic Kidney Disease | Hyperphosphatemia

Japan
Denver Nephrologists, P.C.
CM&D Pharma Limited

Completed

PD Study to Assess Phosphate Binding Characteristics of K2CG Chewing Gum

Chronic Kidney Disease | Hyperphosphatemia

United States
Phosphate Therapeutics
Clinipace Worldwide

Completed

Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease

Hyperphosphataemia
Mitsubishi Tanabe Pharma Corporation

Completed

A Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia

Chronic Kidney Disease | Hyperphosphatemia | Dialysis

France, Poland, Ukraine, United Kingdom, Spain, Serbia, South Africa, Russian Federation, Czech Republic, Germany, Hungary, Italy, Austria, Macedonia, The Former Yugoslav Republic of, Malaysia
AstraZeneca

Completed

30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease

Dyslipidemia | Kidney Disease

United States, Puerto Rico
Medice Arzneimittel Pütter GmbH & Co KG

Completed

Nicotinamide in Hemodialysis Patients With Hyperphosphatemia (DONATO)

Hemodialysis | Chronic Kidney Disease | Hyperphosphatemia

Germany
Herlev Hospital

Completed

Diurnal Variation in Markers of Mineral and Bone Disease in Chronic Kidney Disease

Chronic Kidney Diseases | Mineral Metabolism Disorder

Denmark
Shire

Completed

Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)

Hyperphosphatemia

United States
Mitsubishi Tanabe Pharma Corporation

Terminated

Long-term Extension Study of MCI-196

Chronic Kidney Disease | Hyperphosphatemia | Dialysis | Paediatric

United Kingdom
Fresenius Medical Care North America

Completed

Phosphate Kinetic Modeling (PKM)

End Stage Renal Disease | Hyperphosphatemia

United States
Leiden University Medical Center

Terminated

Rosiglitazone and Insulin Resistance in Renally Impaired Patients

Insulin Resistance | Chronic Kidney Disease

Netherlands
Genzyme, a Sanofi Company

Completed

Post Authorisation Safety Study of Renvela® in Chronic Kidney Disease Patients Not on Dialysis With Hyperphosphataemia

Chronic Kidney Disease | Hyperphosphataemia

France, Germany, Spain, Netherlands, Italy, Austria, Denmark
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety Study of MCI-196 Versus Simvastatin for Dyslipidaemia in Chronic Kidney Disease (CKD) Subjects on Dialysis

Chronic Kidney Disease

Belarus, Bulgaria, Romania, Malaysia, Singapore, Thailand, Italy, Lithuania, Latvia, Croatia, Denmark, Israel, Indonesia
Mitsubishi Tanabe Pharma Corporation

Completed

A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia

Chronic Kidney Disease | Hyperphosphatemia | Dialysis

United States, Puerto Rico
The Hospital for Sick Children

Completed

Omega-3 Fatty Acid Supplementation in Children

Chronic Kidney Disease | Hypertriglyceridemia

Canada
Mitsubishi Tanabe Pharma Corporation

Terminated

Dose-finding Study of MCI-196

Chronic Kidney Disease | Hyperphosphatemia | Dialysis | Paediatric

United Kingdom
Astellas Pharma Inc

Completed

Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis

Renal Insufficiency | Chronic Kidney Disease | Hyperphosphatemia | Renal Dialysis

Japan
Astellas Pharma Inc

Completed

A Phase 3 Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Peritoneal Dialysis

Renal Insufficiency | Chronic Kidney Disease | Renal Dialysis

Japan
Astellas Pharma Inc

Completed

Single and Multiple Dosing Study in Hemodialysis Patients With Hyperphosphatemia in Japan

Chronic Kidney Disease | Hyperphosphatemia Undergoing Hemodialysis

Japan
Ramathibodi Hospital

Completed

Serum Magnesium and Vascular Calcification

Chronic Kidney Disease | Vascular Calcification

Thailand
Ineos Healthcare Limited

Terminated

Phase III Study to Investigate the Safety and Efficacy of Fermagate and Lanthanum Carbonate

Chronic Kidney Failure

United States, Canada, Australia, New Zealand, Brazil, France, Germany, Malta, Poland, South Africa, Spain
Ineos Healthcare Limited

Completed

Dose Ranging Study of Magnesium Iron Hydroxycarbonate in Haemodialysis Subjects With Hyperphosphataemia (ACT3)

Chronic Kidney Failure

United Kingdom

Clinical Trials on Insufficient Metabolic Control

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hungary

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations